Arlington Trust’s Veracyte VCYT Stock Holding History

Arlington Trust’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-56	Closed	-$1.54K	–	880
2023 Q4	$1.54K	Buy	+56	New	+$1.35K	﹤0.01%	710

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Arlington Trust's VCYT Position: Q1 2024 in Review

Arlington Trust sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 56 shares — an estimated $1.54K sold.

Arlington Trust first reported a position in VCYT in Q4 2023 and held it in 1 quarter. The position peaked at $1.54K in Q4 2023. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

Arlington Trust reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 56 Veracyte shares in Q1 2024, an estimated $1.54K.
Arlington Trust first reported a position in Veracyte in Q4 2023 and held it in 1 quarter.
Arlington Trust's Veracyte position peaked at $1.54K in Q4 2023.
246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.